ArticleCancer research and treatment2021

Implications of Tamoxifen Resistance in Palbociclib Efficacy for Patients with Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Subgroup Analyses of KCSG-BR15-10 (YoungPEARL).

Jiyun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.